Pharmacokinetics and dose requirements of vancomycin in neonates.
about
Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunologyInadequate vancomycin therapy in term and preterm neonates: a retrospective analysis of trough serum concentrations in relation to minimal inhibitory concentrationsPopulation pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline.Association between vancomycin trough concentration and area under the concentration-time curve in neonatesDose regimen for vancomycin not needing serum peak levels?Optimization of vancomycin dosing in very low-birth-weight preterm neonates.Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenationVancomycin pharmacokinetics in preterm neonates and the prediction of adult clearanceClinical pharmacokinetics of vancomycin in the neonate: a reviewTowards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling.External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings.Antibiotics and antifungals in neonatal intensive care units: a review.Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations.Vancomycin: a review of population pharmacokinetic analyses.Population pharmacokinetic analysis during the first 2 years of life: an overview.How to use vancomycin optimally in neonates: remaining questions.Renal Function Descriptors in Neonates: Which Creatinine-Based Formula Best Describes Vancomycin Clearance?Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.Assessment of initial vancomycin dosing in neonatesEvaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target.A population pharmacokinetic model for individualised dosage regimens of vancomycin in Chinese neonates and young infants.Individualized Empiric Vancomycin Dosing in Neonates Using a Model-Based Approach.Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
P2860
Q33827819-5B510EF6-9AAF-4186-AA1C-327794E0BE8AQ34014285-3E95A05C-A3A8-488B-9036-68E38E66BCFCQ34381352-F28B05ED-57EB-42CA-B599-4332B24E5916Q34596435-C5D5D4FF-5295-4D99-92C5-B140BBD828F6Q35292492-B5090D5E-6EDB-4366-A7FB-EE9098CA5836Q35564749-8E8DF31D-174F-49AE-BEED-73FBC63AE8B0Q35826801-A2B98D43-0753-4E5F-B231-51C47634B493Q36024899-845D9470-3EA9-460F-AA51-C0C9464D0CC9Q36104107-AC610C06-4F70-4A17-82DD-148FBA465131Q36571794-C14B0C68-C83B-48E2-A72D-C77CAA2DFFD0Q36729959-A8F1DBCD-2782-4195-9572-BD9098A5BFCEQ36740036-31D79927-F666-457C-A684-B5819A24DA0DQ37712974-21424655-A034-40FF-945A-3E989FFF7BFAQ37965578-2C7F1156-D06F-4001-9238-1BCFD2295068Q38062388-3C1E56D3-3AAC-485F-847E-95470ACD028CQ38569678-9B053616-8EAE-495D-9867-BEE410D8FFA4Q38594191-CA20E519-EF97-4FDD-9AD2-A1C499F01989Q38696468-2F04E1EE-1B2E-4CBA-93A1-0531D6B38083Q39110114-1D893219-1E92-41F1-87F6-1F4A3E8E5339Q40327439-40DFC469-FABA-47DE-8AAA-6F28B2D10932Q47183620-F2CE2E1E-0C10-4FF2-A832-33EE445E8228Q47222670-3AC4A317-C7FE-4C9F-BBB9-C7FBA700C135Q47926195-EB642298-C27C-4D36-B959-E31D94C9FD07
P2860
Pharmacokinetics and dose requirements of vancomycin in neonates.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Pharmacokinetics and dose requirements of vancomycin in neonates.
@en
Pharmacokinetics and dose requirements of vancomycin in neonates.
@nl
type
label
Pharmacokinetics and dose requirements of vancomycin in neonates.
@en
Pharmacokinetics and dose requirements of vancomycin in neonates.
@nl
prefLabel
Pharmacokinetics and dose requirements of vancomycin in neonates.
@en
Pharmacokinetics and dose requirements of vancomycin in neonates.
@nl
P2860
P356
P1476
Pharmacokinetics and dose requirements of vancomycin in neonates.
@en
P2093
Grimsley C
Thomson AH
P2860
P304
P356
10.1136/FN.81.3.F221
P577
1999-11-01T00:00:00Z